Suppr超能文献

没食子酰基葡萄糖的分离与鉴定及其对耐多药 和 的活性

Isolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of and .

机构信息

Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Sandering 2, 97074 Wuerzburg, Germany.

School of Pharmacy, Muhimbili University of Health and Allied Sciences, Upanga West, Dar es Salaam P.O. Box 65013, Tanzania.

出版信息

Molecules. 2022 Aug 8;27(15):5045. doi: 10.3390/molecules27155045.

Abstract

The search for new antibiotics against multidrug-resistant (MDR), Gram-negative bacteria is crucial with respect to filling the antibiotics development pipeline, which is subject to a critical shortage of novel molecules. Screening of natural products is a promising approach for identifying antimicrobial compounds hosting a higher degree of novelty. Here, we report the isolation and characterization of four galloylglucoses active against different MDR strains of and . A crude acetone extract was prepared from Linnaeus leaves, and bioautography-guided isolation of active compounds from the extract was performed by liquid-liquid extraction, as well as open column, flash, and preparative chromatographic methods. Isolated active compounds were characterized and elucidated by a combination of spectroscopic and spectrometric techniques. In vitro antimicrobial susceptibility testing was carried out on and using 2 reference strains and 13 strains hosting a wide range of MDR phenotypes. Furthermore, in vivo antibacterial activities were assessed using larvae, and compounds 1,2,3,4,6-penta-O-galloyl-β-d-glucose, 3-O-digalloyl-1,2,4,6-tetra-O-galloyl-β-d-glucose, 6-O-digalloyl-1,2,3,4-tetra-O-galloyl-β-d-glucose, and 3,6-bis-O-digalloyl-1,2,4-tri-O-galloyl-β-d-glucose were isolated and characterized. They showed minimum inhibitory concentration (MIC) values in the range of 2-256 µg/mL across tested bacterial strains. These findings have added to the number of known galloylglucoses from and highlight their potential against MDR Gram-negative bacteria.

摘要

寻找针对多药耐药(MDR)革兰氏阴性菌的新型抗生素对于填补抗生素开发管道至关重要,因为新型分子严重短缺。筛选天然产物是发现具有更高新颖度的抗菌化合物的有前途的方法。在这里,我们报告了四种针对不同 MDR 株和 的酰基葡萄糖的分离和表征。从林奈氏叶中制备丙酮粗提取物,并通过液液萃取以及开放柱、闪蒸和制备色谱法从提取物中进行生物自显影指导的活性化合物分离。通过光谱和光谱技术的组合对分离出的活性化合物进行了表征和阐明。使用 2 个参考菌株和 13 个具有广泛 MDR 表型的菌株对 和 进行了体外抗菌药敏试验。此外,使用 幼虫评估了化合物 1、2、3、4、6-五-O-酰基-β-d-葡萄糖、3-O-二酰基-1、2、4、6-四-O-酰基-β-d-葡萄糖、6-O-二酰基-1、2、3、4-四-O-酰基-β-d-葡萄糖和 3,6-双-O-二酰基-1、2、4-三-O-酰基-β-d-葡萄糖的体内抗菌活性。它们在测试的细菌菌株中表现出 2-256µg/mL 的最小抑菌浓度(MIC)值。这些发现增加了来自和的已知酰基葡萄糖的数量,并突出了它们对 MDR 革兰氏阴性菌的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcc/9370434/341603e775a8/molecules-27-05045-sch001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验